Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H33N9O15P2 |
| Molecular Weight | 785.5497 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N4C=NC5=C4N=CN=C5N)C6=NC(=O)NC(=O)C6=N2
InChI
InChIKey=VWWQXMAJTJZDQX-UYBVJOGSSA-N
InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1
| Molecular Formula | C27H33N9O15P2 |
| Molecular Weight | 785.5497 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.wikidoc.org/index.php/FAD
http://www.drugbank.ca/drugs/DB03147
Curator's Comment: description was created based on several sources, including:
http://www.wikidoc.org/index.php/FAD
http://www.drugbank.ca/drugs/DB03147
Flavin adenine dinucleotide is a coenzyme form of vitamin B2. Many oxidoreductases, called flavoenzymes or flavoproteins, require FAD as a prosthetic group, which functions in electron transfers. It is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency or metabolic disorder including stomatitis, eczema, etc. No adverse reactions were reported.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Flavitan Approved UseIt is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency Launch Date1966 |
|||
| Palliative | Flavitan Approved UseIt is an effective in conjunctivitis treatment. Launch Date1966 |
|||
| Palliative | Flavitan Approved UseIt is usually used for the prevention and treatment of metabolic disorder including stomatitis. Launch Date1966 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships. | 2015-06-05 |
|
| Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin. | 2011-04 |
|
| Identification and functional characterization of rat riboflavin transporter 2. | 2009-04 |
|
| Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient. | 2006-03 |
|
| Architecture of succinate dehydrogenase and reactive oxygen species generation. | 2003-01-31 |
|
| Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase. | 2001-11 |
|
| Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. | 2001-03 |
|
| Cloning, heterologous expression, and enzymological characterization of human squalene monooxygenase. | 2000-02-15 |
|
| Structure of fumarate reductase from Wolinella succinogenes at 2.2 A resolution. | 1999-11-25 |
|
| Determination of riboflavin and flavocoenzymes in human blood plasma by high-performance liquid chromatography. | 1995 |
|
| Flavin adenine dinucleotide levels in erythrocytes of very low birthweight infants under vitamin supplementation. | 1993 |
|
| [Comparison of biochemical criteria for supplying the human body with riboflavin]. | 1991-09-01 |
|
| Nutritional status in anorexia nervosa: clinical chemistry, vitamins, iron and zinc. | 1988-11 |
|
| Riboflavin metabolism in the hypothyroid newborn. | 1988-03 |
|
| Quantification of riboflavin, riboflavin 5'-phosphate and flavin adenine dinucleotide in plasma and urine by high-performance liquid chromatography. | 1987-12-25 |
|
| Riboflavin metabolism in the hypothyroid human adult. | 1987-02 |
|
| ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity. | 1982-05 |
|
| Mechanism of chlorpromazine-induced arrhythmia -- arrhythmia and mitochondrial dysfunction. | 1981-07 |
|
| Protection of chlorpromazine-induced arrhythmia by flavin-adenine-dinucleotide in canine heart. | 1979-09 |
|
| Flavin adenine dinucleotide concentration in erythrocytes with normal and deficient glucose-6-phosphate dehydrogenase. | 1970-09-01 |
Patents
Sample Use Guides
Oral: Take 5 to 45 mg of flavin adenine dinucleotide per day in 1 to 3 divided doses.
Injection: 40 mg one or two times per day
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5822598
The addition of 1uM of FAD was found to exert a consistent activation effect on Glutathione reductase activity.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:49:04 GMT 2025
by
admin
on
Mon Mar 31 18:49:04 GMT 2025
|
| Record UNII |
ZC44YTI8KK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
53647-4
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
||
|
LOINC |
78991-7
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
||
|
LOINC |
78990-9
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
||
|
LOINC |
2281-4
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
||
|
NCI_THESAURUS |
C26017
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
146-14-5
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
ZC44YTI8KK
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
DB03147
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
16238
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
m5392
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
205-663-1
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
ZC44YTI8KK
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
DTXSID4048307
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
SUB13892MIG
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
FLAVIN ADENINE DINUCLEOTIDE
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
100000078499
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
643975
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
C80888
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
1314412
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL1232653
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY | |||
|
112207
Created by
admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |